Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Technology Background
- Omics Types
- Various Multiomics Approaches and Applications
- Technological Infrastructure and Data Integration
- PESTEL Analysis
- Political
- Economic
- Social
- Technological
- Environmental
- Legal
- Regulatory Landscape
- Federal Regulation
- CMS Regulation
- U.S. Food and Drug Administration Regulation
- U.S. Federal Trade Commission Regulation
- Strategic Recommendations
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Rapid Advances in Multiomics Research and its Applications
- Favorable Funding Scenario for Multiomics Research Activities
- Decrease in DNA-Sequencing Method Prices
- Growing Prevalence of Cancer Generating Demand for Personalized Treatments
- Promising Applications of Multiomics in the Drug Development Process
- Market Restraints
- Lack of Data Standardization
- Market Opportunities
- Expanding Single-Cell Multiomics Applications
Chapter 4 Emerging Technologies and Developments
- Artificial Intelligence in Multiomics
- Companies in the Artificial Intelligence Multiomics Market
- Advances in Single-Cell Omics and Multiomics
Chapter 5 Market Segmentation Analysis
- Key Market Trends
- Segmentation Breakdown
- Global Market for Multiomics by Product
- Instruments
- Consumables
- Software and Services
- Global Market for Multiomics by Platform
- Genomics
- Proteomics
- Transcriptomics
- Metabolomics
- Other Platforms
- Global Market for Multiomics by Application
- Oncology
- Immunology
- Neurology
- Cell Biology
- Other Applications
- Global Market for Multiomics by End User
- Academic Research Organizations
- Pharmaceutical and Biotechnology Companies
- Clinical and Hospital Laboratories
- Other End Users
- Geographic Breakdown
- Global Multiomics Market by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Top Players Ranking
- Key Strategies Adopted by Players
- Collaborations and Partnerships
- New Product Launches
- Expansions and Investments
- Mergers and Acquisitions
- Agreements
- Patent Analysis
Chapter 7 Sustainability in Multiomics Market: ESG Perspective
- Introduction to ESG
- ESG Performance in Market
- ESG Practices in the Multiomics Industry
- Concluding Remarks
Chapter 9 Company Profiles
- Agilent Technologies Inc.
- Beckman Coulter Inc. (Subsidiary of Danaher Corp.)
- Bio-Rad Laboratories Inc.
- BD
- Bruker
- BGI
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Qiagen
- Revvity
- Standard BioTools
- Thermo Fisher Scientific Inc.
List of Tables
Summary Table A: Global Market for Multiomics, by Product, Through 2029
Summary Table B: Global Market for Multiomics, by Region, Through 2029
Table 1: Multiomics Approaches and Their Molecular Readouts
Table 2: Molecular Biology Technologies for Multiomics Approaches
Table 3: Single-Cell and Spatial Omics Technologies, 2018-2023
Table 4: Publicly Available Omics Data in the Cancer Research Field
Table 5: Multiomics’ Role During Various Stages of Drug Development Process
Table 6: Companies in the Artificial Intelligence Multiomics Market
Table 7: Global Market for Multiomics, by Product, Through 2029
Table 8: Global Market for Multiomics for Instruments, by Region, Through 2029
Table 9: Global Market for Multiomics for Consumables, by Region, Through 2029
Table 10: Global Market for Multiomics for Software and Services, by Region, Through 2029
Table 11: Global Market for Multiomics, by Platform, Through 2029
Table 12: Global Market for Multiomics for Genomics, by Region, Through 2029
Table 13: Global Market for Multiomics for Proteomics, by Region, Through 2029
Table 14: Global Market for Multiomics for Transcriptomics, by Region, Through 2029
Table 15: Global Market for Multiomics for Metabolomics, by Region, Through 2029
Table 16: Global Market for Multiomics for Other Platforms, by Region, Through 2029
Table 17: Global Market for Multiomics, by Application, Through 2029
Table 18: Global Market for Multiomics for Oncology, by Region, Through 2029
Table 19: Global Market for Multiomics for Immunology, by Region, Through 2029
Table 20: Global Market for Multiomics for Neurology, by Region, Through 2029
Table 21: Global Market for Multiomics for Cell Biology, by Region, Through 2029
Table 22: Global Market for Multiomics for Other Applications, by Region, Through 2029
Table 23: Global Market for Multiomics, by End User, Through 2029
Table 24: Global Market for Multiomics for Academic Research Organizations, by Region, Through 2029
Table 25: Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, Through 2029
Table 26: Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, Through 2029
Table 27: Global Market for Multiomics for Other End Users, by Region, Through 2029
Table 28: Global Market for Multiomics, by Region, Through 2029
Table 29: North American Market for Multiomics, by Product, Through 2029
Table 30: North American Market for Multiomics, by Platform, Through 2029
Table 31: North American Market for Multiomics, by Application, Through 2029
Table 32: North American Market for Multiomics, by End User, Through 2029
Table 33: European Initiatives Focused on Omics Research for Personalized Medicine
Table 34: European Market for Multiomics, by Product, Through 2029
Table 35: European Market for Multiomics, by Platform, Through 2029
Table 36: European Market for Multiomics, by Application, Through 2029
Table 37: European Market for Multiomics, by End User, Through 2029
Table 38: Asia-Pacific Market for Multiomics, by Product, Through 2029
Table 39: Asia-Pacific Market for Multiomics, by Platform, Through 2029
Table 40: Asia-Pacific Market for Multiomics, by Application, Through 2029
Table 41: Asia-Pacific Market for Multiomics, by End User, Through 2029
Table 42: Rest of the World Market for Multiomics, by Product, Through 2029
Table 43: Rest of the World Market for Multiomics, by Platform, Through 2029
Table 44: Rest of the World Market for Multiomics, by Application, Through 2029
Table 45: Rest of the World Market for Multiomics, by End User, Through 2029
Table 46: Top Players in Multiomics Market, 2023
Table 47: Collaborations and Partnerships: Multiomics Market, 2021-2024
Table 48: New Product Launches: Multiomics Market, 2021-2024
Table 49: Expansions and Investments: Multiomics Market, 2021-2024
Table 50: Mergers and Acquisitions: Multiomics Market, 2020-2024
Table 51: Agreements: Multiomics Market, 2022-2024
Table 52: Multiomics Market: Patent Analysis, 2018-2023
Table 53: Key Focus Areas in ESG Metrics
Table 54: Environmental Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 55: Social Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 56: Governance Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 57: ESG Rankings for Multiomics Companies, 2024*
Table 58: Acronyms Used in this Report
Table 59: Agilent Technologies Inc.: Company Snapshot
Table 60: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 61: Agilent Technologies Inc.: Product Portfolio
Table 62: Agilent Technologies Inc.: News/Key Developments, 2023
Table 63: Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
Table 64: Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
Table 65: Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2023
Table 66: Bio-Rad Laboratories Inc.: Company Snapshot
Table 67: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 68: Bio-Rad Laboratories Inc.: Product Portfolio
Table 69: Bio-Rad Laboratories Inc.: News/Key Developments, 2020
Table 70: BD: Company Snapshot
Table 71: BD: Financial Performance, FY 2022 and 2023
Table 72: BD: Product Portfolio
Table 73: BD: News/Key Developments, 2024
Table 74: Bruker: Company Snapshot
Table 75: Bruker: Financial Performance, FY 2022 and 2023
Table 76: Bruker: Product Portfolio
Table 77: Bruker: News/Key Developments, 2024
Table 78: BGI: Company Snapshot
Table 79: BGI: Product Portfolio
Table 80: BGI: News/Key Developments, 2024
Table 81: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 82: F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 83: F. Hoffman-La Roche Ltd.: Product Portfolio
Table 84: F. Hoffman-La Roche Ltd.: News/Key Developments, 2022
Table 85: Illumina Inc.: Company Snapshot
Table 86: Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 87: Illumina Inc.: Product Portfolio
Table 88: Illumina Inc.: News/Key Developments, 2023
Table 89: QIAGEN: Company Snapshot
Table 90: QIAGEN: Financial Performance, FY 2022 and 2023
Table 91: QIAGEN: Product Portfolio
Table 92: QIAGEN: News/Key Developments, 2024
Table 93: Revvity: Company Snapshot
Table 94: Revvity: Financial Performance, FY 2022 and 2023
Table 95: Revvity: Product Portfolio
Table 96: Revvity: News/Key Developments, 2023
Table 97: Standard BioTools: Company Snapshot
Table 98: Standard BioTools: Financial Performance, FY 2022 and 2023
Table 99: Standard BioTools: Product Portfolio
Table 100: Standard BioTools: News/Key Developments, 2024
Table 101: Thermo Fisher Scientific Inc.: Company Snapshot
Table 102: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 103: Thermo Fisher Scientific Inc.: Product Portfolio
Table 104: Thermo Fisher Scientific Inc.: News/Key Developments, 2024
List of Figures
Summary Figure A: Global Market for Multiomics, by Product, 2021-2029
Summary Figure B: Global Market for Multiomics, by Region, 2021-2029
Figure 1: Omics Types
Figure 2: Applications of Multiomics Approaches
Figure 3: PESTEL Analysis: Multiomics Market
Figure 4: Strategic Recommendations: Multiomics Market
Figure 5: Multiomics Market Dynamics
Figure 6: Average Cost Per Genome: Year-on-Year Trend, 2011-2022
Figure 7: Global Market Shares for Multiomics, by Product, 2024
Figure 8: Global Market for Multiomics for Instruments, by Region, 2021-2029
Figure 9: Global Market for Multiomics for Consumables, by Region, 2021-2029
Figure 10: Global Market for Multiomics for Software and Services, by Region, 2021-2029
Figure 11: Global Market Shares for Multiomics, by Platform, 2024
Figure 12: Global Market for Multiomics for Genomics, by Region, 2021-2029
Figure 13: Global Market for Multiomics for Proteomics, by Region, 2021-2029
Figure 14: Global Market for Multiomics for Transcriptomics, by Region, 2021-2029
Figure 15: Global Market for Multiomics for Metabolomics, by Region, 2021-2029
Figure 16: Global Market for Multiomics for Other Platforms, by Region, 2021-2029
Figure 17: Major Applications of Multiomics
Figure 18: Global Market Shares for Multiomics, by Application, 2024
Figure 19: Global Market for Multiomics for Oncology, by Region, 2021-2029
Figure 20: Global Market for Multiomics for Immunology, by Region, 2021-2029
Figure 21: Global Market for Multiomics for Neurology, by Region, 2021-2029
Figure 22: Global Market for Multiomics for Cell Biology, by Region, 2021-2029
Figure 23: Global Market for Multiomics for Other Applications, by Region, 2021-2029
Figure 24: Global Market Shares for Multiomics, by End User, 2024
Figure 25: Global Market for Multiomics for Academic Research Organizations, by Region, 2021-2029
Figure 26: Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, 2021-2029
Figure 27: Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, 2021-2029
Figure 28: Global Market for Multiomics for Other End Users, by Region, 2021-2029
Figure 29: Global Market Shares of Multiomics, by Region, 2024
Figure 30: North American Market for Multiomics, by Product, 2021-2029
Figure 31: North American Market for Multiomics, by Platform, 2021-2029
Figure 32: North American Market for Multiomics, by Application, 2021-2029
Figure 33: North American Market for Multiomics, by End User, 2021-2029
Figure 34: European Market for Multiomics, by Product, 2021-2029
Figure 35: European Market for Multiomics, by Platform, 2021-2029
Figure 36: European Market for Multiomics, by Application, 2021-2029
Figure 37: European Market for Multiomics, by End User, 2021-2029
Figure 38: Asia-Pacific Multiomics Market Growth Drivers
Figure 39: Asia-Pacific Market for Multiomics, by Product, 2021-2029
Figure 40: Asia-Pacific Market for Multiomics, by Platform, 2021-2029
Figure 41: Asia-Pacific Market for Multiomics, by Application, 2021-2029
Figure 42: Asia-Pacific Market for Multiomics, by End User, 2021-2029
Figure 43: Rest of the World Market for Multiomics, by Product, 2021-2029
Figure 44: Rest of the World Market for Multiomics, by Platform, 2021-2029
Figure 45: Rest of the World Market for Multiomics, by Application, 2021-2029
Figure 46: Rest of the World Market for Multiomics, by End User, 2021-2029
Figure 47: Global Multiomics Market Competitive Intelligence, 2020-2024
Figure 48: Patents, 2018-2023
Figure 49: How a Strong ESG Proposition Benefits Businesses
Figure 50: Biotech Companies Providing ESG Disclosure, 2022
Figure 51: Location of ESG Disclosure, 2022
Figure 52: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 53: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 54: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 55: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 56: BD: Revenue Share, by Business Unit, FY 2023
Figure 57: BD: Revenue Share, by Country/Region, FY 2023
Figure 58: Bruker: Revenue Share, by Business Unit, FY 2023
Figure 59: Bruker: Revenue Share, by Country/Region, FY 2023
Figure 60: F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 61: F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 62: Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 63: Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 64: QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 65: QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 66: Revvity: Revenue Share, by Business Unit, FY 2023
Figure 67: Revvity: Revenue Share, by Country/Region, FY 2023
Figure 68: Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 69: Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 70: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 71: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
